Cytek Biosciences (CTKB) Change in Inventory (2020 - 2026)

Cytek Biosciences has reported Change in Inventory for 7 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 8.25% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 163.31% YoY), and the FY2025 full-year result was $5.2 million, up 135.54% from the prior year.
• Change in Inventory for Q1 2026 stood at $1.6 million, up from -$2.1 million in the prior quarter.
• The five-year high for Change in Inventory was $8.4 million in Q2 2022, with the low at -$6.3 million in Q4 2023.
• Historically, Change in Inventory has averaged $322529.4 across 5 years, with a median of $1.5 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Inventory jumped 3143.85% — and 2024, when it plunged 288.35%.
• Cytek Biosciences' Change in Inventory stood at -$1.9 million in 2022, then sank by 236.15% to -$6.3 million in 2023, then jumped by 68.42% to -$2.0 million in 2024, then decreased by 2.55% to -$2.1 million in 2025, then surged by 179.33% to $1.6 million in 2026.
• The last three Change in Inventory figures came in at $1.6 million (Q1 2026), -$2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.